Observations, page-4

Excellent post @GoldStar112. Yes indeed, these things need to be tested.

We are assuming that if NOX had dedicated 100% to the radonc pillar they may well be able to get DARRT-2 moving a lot more quickly, which is a fair assumption.

But even given that, your strategy B) is the correct one in my opinion. It will prove to be far more lucrative in the long term.Strategy A) delivers quicker value and quicker shareholder returns but potentially leaves a lot of money on the table, and at greater risk of complete company washout should that single shot on goal miss.

NOX is extremely well funded and backed by some stable "high net worth" individuals. This gives a good backbone to take on the longer but more lucrative strategy. As GK has said, this is the culmination of his life's work (and literally, his own life saving work), and he is obviously not in this for the money. Well, maybe for some of the monies. But I'm pretty sure that is not his motivation here.

As a shareholder though, of course it is natural to want fast returns so I too am frustrated at slow progress from time to time. But having been invested and following for so many years now, the science still stacks up and continues to paint a very compelling picture.

And as always, the disclaimer: this is a speculative biotech, don't put in more than can afford to lose, be prepared to retire early if this thing 100 bags, yadda yadda yadda.